← Back
▼ SELL

$ Value

$173K

Shares

4,573

Price

$38

Filed

Mar 4

Insider

Name

Davis John E

Title

Chief Commercial Officer

CIK

0001653206

Roles

Officer

Transaction Details

Transaction Date

2026-03-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

230,794

Footnotes

Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date. | These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.

Filing Info

Accession No.

0001628280-26-014892

Form Type

4

Issuer CIK

0000784199

Davis John E's History

Date Ticker Type Value
2026-03-03 AORT $173K
2026-03-02 AORT $106K
2026-03-02 AORT A $0
2026-02-24 AORT $74K
2026-02-24 AORT A $0
2026-02-23 AORT $142K
2025-12-15 AORT $226K
2025-11-17 AORT M $189K
2025-11-17 AORT $289K
2025-11-17 AORT M $0

Other Insiders at AORT (90d)

Insider Bought Sold Last
Horton Amy
VP, Chief Accounting Officer
$153K 2026-03-03
Mackin James P
President & CEO
$2.5M 2026-03-03
Berry Lance A
EVP, COO, CFO & Treasurer
$783K 2026-03-03
Holloway Jean F
SVP, General Counsel
$744K 2026-03-04
Davis John E
Chief Commercial Officer
$322K 2026-03-02
Stanton Marshall S.
SVP, Clinical & MD Affair
$275K 2026-03-03